These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 19451719)

  • 1. Association of the c.3972C>T variant of the multidrug resistance-associated protein 2 Gene (MRP2/ABCC2) with susceptibility to bile duct cancer.
    Hoblinger A; Grunhage F; Sauerbruch T; Lammert F
    Digestion; 2009; 80(1):36-9. PubMed ID: 19451719
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Wilson disease, ABCC2 c.3972C > T polymorphism and primary liver cancers: suggestions from a familial cluster.
    Brandi G; Rizzo A; Deserti M; Relli V; Indio V; Bin S; Pariali M; Palloni A; De Lorenzo S; Tovoli F; Tavolari S
    BMC Med Genet; 2020 Nov; 21(1):225. PubMed ID: 33208122
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A common variant in the precursor miR-146a sequence does not predispose to cholangiocarcinoma in a large European cohort.
    Mihalache F; Hoblinger A; Acalovschi M; Sauerbruch T; Lammert F; Zimmer V
    Hepatobiliary Pancreat Dis Int; 2012 Aug; 11(4):412-7. PubMed ID: 22893469
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MRP2 haplotypes confer differential susceptibility to toxic liver injury.
    Choi JH; Ahn BM; Yi J; Lee JH; Lee JH; Nam SW; Chon CY; Han KH; Ahn SH; Jang IJ; Cho JY; Suh Y; Cho MO; Lee JE; Kim KH; Lee MG
    Pharmacogenet Genomics; 2007 Jun; 17(6):403-15. PubMed ID: 17502832
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of genetic polymorphisms on intestinal expression and rifampicin-type induction of ABCC2 and on bioavailability of talinolol.
    Haenisch S; May K; Wegner D; Caliebe A; Cascorbi I; Siegmund W
    Pharmacogenet Genomics; 2008 Apr; 18(4):357-65. PubMed ID: 18334920
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lack of association between ABCC2 gene variants and treatment response in epilepsy.
    Hilger E; Reinthaler EM; Stogmann E; Hotzy C; Pataraia E; Baumgartner C; Zimprich A; Zimprich F
    Pharmacogenomics; 2012 Jan; 13(2):185-90. PubMed ID: 22256867
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The ABCC2 c.-24C>T polymorphism increases the risk of resistance to antiepileptic drugs: A meta-analysis.
    Qian L; Fang S; Yan YL; Zeng SS; Xu ZJ; Gong ZC
    J Clin Neurosci; 2017 Mar; 37():6-14. PubMed ID: 27816260
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of polymorphisms of ABCB1 and ABCC2 on mRNA and protein expression in normal and cancerous kidney cortex.
    Haenisch S; Zimmermann U; Dazert E; Wruck CJ; Dazert P; Siegmund W; Kroemer HK; Warzok RW; Cascorbi I
    Pharmacogenomics J; 2007 Feb; 7(1):56-65. PubMed ID: 16788565
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic association analysis of transporters identifies ABCC2 loci for seizure control in women with epilepsy on first-line antiepileptic drugs.
    Grover S; Gourie-Devi M; Bala K; Sharma S; Kukreti R
    Pharmacogenet Genomics; 2012 Jun; 22(6):447-65. PubMed ID: 22565165
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cholangiocarcinoma in primary sclerosing cholangitis is associated with NKG2D polymorphisms.
    Melum E; Karlsen TH; Schrumpf E; Bergquist A; Thorsby E; Boberg KM; Lie BA
    Hepatology; 2008 Jan; 47(1):90-6. PubMed ID: 18023027
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of NRF2 polymorphism with cholangiocarcinoma prognosis in Thai patients.
    Khunluck T; Kukongviriyapan V; Puapairoj A; Khuntikeo N; Senggunprai L; Zeekpudsa P; Prawan A
    Asian Pac J Cancer Prev; 2014; 15(1):299-304. PubMed ID: 24528044
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic variants may play an important role in mRNA-miRNA interaction: evidence for haplotype-dependent downregulation of ABCC2 (MRP2) by miRNA-379.
    Werk AN; Bruckmueller H; Haenisch S; Cascorbi I
    Pharmacogenet Genomics; 2014 Jun; 24(6):283-91. PubMed ID: 24743544
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MYH rs3219476 and rs3219472 polymorphisms and risk of cholangiocarcinoma.
    You SH; Wang X; Huang S; Wang M; Ji GZ; Xia JR; Fan ZN
    Mol Med Rep; 2013 Jan; 7(1):347-51. PubMed ID: 23138270
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional characterization of ABCC2 promoter polymorphisms and allele-specific expression.
    Nguyen TD; Markova S; Liu W; Gow JM; Baldwin RM; Habashian M; Relling MV; Ratain MJ; Kroetz DL
    Pharmacogenomics J; 2013 Oct; 13(5):396-402. PubMed ID: 22664480
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selected ABCB1, ABCB4 and ABCC2 polymorphisms do not enhance the risk of drug-induced hepatotoxicity in a Spanish cohort.
    Ulzurrun E; Stephens C; Ruiz-Cabello F; Robles-Diaz M; Saenz-López P; Hallal H; Soriano G; Roman E; Fernandez MC; Lucena MI; Andrade RJ
    PLoS One; 2014; 9(4):e94675. PubMed ID: 24732756
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of genetic polymorphism in ABCC2 with hepatic multidrug resistance-associated protein 2 expression and pravastatin pharmacokinetics.
    Niemi M; Arnold KA; Backman JT; Pasanen MK; Gödtel-Armbrust U; Wojnowski L; Zanger UM; Neuvonen PJ; Eichelbaum M; Kivistö KT; Lang T
    Pharmacogenet Genomics; 2006 Nov; 16(11):801-8. PubMed ID: 17047488
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of ABCC2 genotype on antiepileptic drug response in Caucasian patients with childhood epilepsy.
    Ufer M; von Stülpnagel C; Muhle H; Haenisch S; Remmler C; Majed A; Plischke H; Stephani U; Kluger G; Cascorbi I
    Pharmacogenet Genomics; 2011 Oct; 21(10):624-30. PubMed ID: 21799461
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The association of transporter ABCC2 (MRP2) genetic variation and drug-induced hyperbilirubinemia.
    Huang YS; Chang TE; Perng CL; Huang YH
    J Chin Med Assoc; 2021 Feb; 84(2):129-135. PubMed ID: 33323685
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Non-response to antiepileptic pharmacotherapy is associated with the ABCC2 -24C>T polymorphism in young and adult patients with epilepsy.
    Ufer M; Mosyagin I; Muhle H; Jacobsen T; Haenisch S; Häsler R; Faltraco F; Remmler C; von Spiczak S; Kroemer HK; Runge U; Boor R; Stephani U; Cascorbi I
    Pharmacogenet Genomics; 2009 May; 19(5):353-62. PubMed ID: 19415824
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic susceptibility to diclofenac-induced hepatotoxicity: contribution of UGT2B7, CYP2C8, and ABCC2 genotypes.
    Daly AK; Aithal GP; Leathart JB; Swainsbury RA; Dang TS; Day CP
    Gastroenterology; 2007 Jan; 132(1):272-81. PubMed ID: 17241877
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.